Enjoy complimentary customisation on priority with our Enterprise License!
The cell culture media and reagents market size is forecast to increase by USD 5.17 billion, at a CAGR of 8.11% between 2023 and 2028.
The market continues to evolve, driven by advancements in various sectors including stem cell research, in vitro diagnostics, and gene therapy. Primary cells, cell lines, and cell culture techniques are integral components of this dynamic market. Cell culture media, a crucial element in maintaining cell health and viability, is undergoing constant innovation with the development of serum-free media and basal media for specific cell types. Cell characterization and quality assurance are paramount in ensuring the efficacy of cell-based assays and therapeutic applications. In the realm of gene therapy, the demand for high-quality cell lines and media is escalating, as is the need for process development and downstream processing solutions.
In vitro diagnostics and pharmaceutical research are also significant contributors to the market's growth. Three-dimensional cell culture techniques and tissue engineering are gaining traction, necessitating advanced growth media and cell culture optimization strategies. Flow cytometry and cell morphology analysis play a vital role in monitoring cell proliferation, differentiation, and cell viability. The integration of therapeutic antibodies and recombinant proteins in cell culture systems further expands the market's scope. Cell line development, tissue engineering, and regenerative medicine are paving the way for novel therapeutic approaches. The single-use bioreactor and high-throughput screening technologies are essential tools in the development of these advanced applications.
Quality control and quality assurance are essential aspects of the market, ensuring the production of reliable and consistent products. The ongoing process of optimizing cell culture techniques and media formulations continues to unfold, driving market growth and innovation.
The cell culture media and reagents industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The pharmaceutical and biotechnology industry segment is estimated to witness significant growth during the forecast period.
The pharmaceutical and biotechnology sector is witnessing significant growth as companies invest heavily in research and development (R&D) for the discovery and production of new drugs to address prevalent and emerging diseases. This shift in focus towards cell and gene therapy is driven by the potential of these treatments to provide effective solutions using engineered proteins, antibodies, and small molecules. For instance, the FDA's approval of the PROVENGE drug, which is a cell therapy product, underscores this trend. In vitro diagnostics, primary cells, and cell lines are crucial components in the development of these therapies.
Cell culture media and techniques, including serum-free media and 3D cell culture, play a vital role in maintaining cell viability, proliferation, and differentiation during the development process. Gene therapy and regenerative medicine applications require rigorous cell characterization, quality assurance, and quality control to ensure safety and efficacy. Cell-based assays, flow cytometry, and cell morphology analysis are essential tools for monitoring cell health and assessing cellular responses. Downstream processing, including protein purification and formulation development, is crucial for the production of recombinant proteins and therapeutic antibodies. Pharmaceutical research, academic institutions, and biotech companies are collaborating to optimize cell culture media, cell line development, and process development using single-use bioreactors and tissue engineering techniques.
High-throughput screening and cell banking are also essential for the efficient identification and preservation of promising cell lines and therapeutic candidates. These advancements in cell culture media and reagents are propelling the industry forward, enabling the production of innovative therapeutics and contributing to the growth of the pharmaceutical and biotechnology sector.
The Pharmaceutical and biotechnology industry segment was valued at USD 2.85 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 37% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The prevalence of chronic and infectious diseases, such as cancer, in North America has significantly increased, with an estimated 2.01 million new cancer cases and 611,720 deaths in the US in 2024, according to the National Institutes of Health (NIH). This trend has fueled the demand for research and development of new drugs and biologics, leading to a surge in demand for cell culture media and reagents. These essential components of cell culture techniques are used extensively in the production of primary cells, cell lines, and stem cells for various applications, including gene therapy, tissue engineering, pharmaceutical research, and drug discovery.
Cell culture media and reagents are integral to maintaining the health and viability of cells during in vitro diagnostics, cell characterization, and cell-based assays. Growth media, serum-free media, and basal media are essential for cell proliferation and differentiation, while cell morphology and cell viability are assessed using techniques such as flow cytometry and microscopy. Moreover, the advancements in cell culture optimization, 3D cell culture, and downstream processing have enabled the production of recombinant proteins, therapeutic antibodies, and cell lines for use in regenerative medicine and cell therapy. The single-use bioreactor and process development have streamlined the production of these biologics, ensuring consistent quality and reducing contamination risks.
Academic research and quality assurance and control are also significant contributors to the market, as they require large volumes of these essential reagents for research and development activities. High-throughput screening and quality control techniques are crucial for ensuring the purity and consistency of these biologics, making cell culture media and reagents indispensable tools in the scientific community.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The cell culture media and reagents market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cell culture media and reagents market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, cell culture media and reagents market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Thermo Fisher Scientific - The company specializes in providing cell culture media and reagents, including basal media, serum-free media, and cell culture supplements, for scientific research applications. These essential components facilitate optimal cell growth and development in laboratory settings. The media and reagents are designed to meet rigorous research standards, ensuring consistency and reliability in experimental outcomes. By offering a comprehensive range of cell culture solutions, the company empowers researchers to advance their discoveries and make significant contributions to their respective fields.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Cell Culture Media And Reagents Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
173 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.11% |
|
Market growth 2024-2028 |
USD 5165.4 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
8.02 |
|
Key countries |
US, Japan, China, Canada, Germany, UK, France, India, South Korea, UAE, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this cell culture media and reagents market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Market Segmentation by Application
9 Market Segmentation by Technology
10 Market Segmentation by Media Type
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
